Takaki M, Branchek T, Tamir H, Gershon M D
J Neurosci. 1985 Jul;5(7):1769-80. doi: 10.1523/JNEUROSCI.05-07-01769.1985.
Research on the role of serotonin (5-hydroxytryptamine, 5-HT) in the function of the enteric nervous system has been impeded by the lack of specific inhibitors of the enteric neural actions of 5-HT. Saturable, reversible, high affinity enteric binding sites for 3H-5-HT have recently been characterized and radioautographically located. Affinity for the 3H-5-HT binding site requires an indole ring substituted with a free hydroxyl group. These 3H-5-HT binding sites have been proposed to be enteric neural 5-HT receptors. This hypothesis was tested in the current study by comparing the ability of compounds to inhibit the binding of 3H-5-HT with their electrophysiologically determined actions on myenteric neurons. 5-Methoxytryptamine did not inhibit the binding of 3H-5-HT to enteric membranes and neither mimicked nor antagonized the effects of 5-HT on the membrane potential of myenteric neurons. Two dipeptides of 5-hydroxytryptophan, N-acetyl- and N-hexanoyl-5-hydroxytryptophyl-5-hydroxytryptophan amide (5-HTP-DP and N-hex-5-HTP-DP) inhibited the binding of 3H-5-HT (K1 = 0.25 microM for 5-HTP-DP and 1.19 microM for N-hex-5-HTP-DP). 5-HTP-DP applied by pressure microejection or superfusion (10 microM) antagonized the slow postsynaptic depolarization of myenteric neurons evoked by microejection of 5-HT. 5-HTP-DP also blocked the 5-HT-induced presynaptic reduction in amplitude of nicotinic fast synaptic potentials; however, 5-HTP-DP itself did not affect these responses. Moreover, 5-HTP-DP also failed to affect responses of myenteric neurons to microejected substance P, their muscarinic response to acetylcholine, or antidromic action potentials. In contrast, both dipeptides blocked the slow synaptic potentials seen in type II/AH neurons following stimulation of fiber tracts in interganglionic connectives. These data support the hypotheses that enteric 3H-5-HT binding sites are enteric neural 5-HT receptors, that dipeptides of 5-hydroxytryptophan are specific antagonists at these receptors, and that 5-HT is one of the mediators of slow synaptic potentials in the myenteric plexus.
由于缺乏5-羟色胺(5-HT)肠道神经作用的特异性抑制剂,关于5-羟色胺(血清素,5-HT)在肠神经系统功能中的作用的研究受到了阻碍。最近已对3H-5-HT的可饱和、可逆、高亲和力肠道结合位点进行了表征并通过放射自显影定位。对3H-5-HT结合位点的亲和力要求吲哚环被一个游离羟基取代。这些3H-5-HT结合位点被认为是肠道神经5-HT受体。在本研究中,通过比较化合物抑制3H-5-HT结合的能力与其对肌间神经丛神经元的电生理学测定作用,对这一假设进行了检验。5-甲氧基色胺不抑制3H-5-HT与肠道膜的结合,既不模拟也不拮抗5-HT对肌间神经丛神经元膜电位的影响。5-羟色氨酸的两种二肽,N-乙酰基-和N-己酰基-5-羟色氨酰-5-羟色氨酸酰胺(5-HTP-DP和N-hex-5-HTP-DP)抑制3H-5-HT的结合(5-HTP-DP的K1 = 0.25 microM,N-hex-5-HTP-DP的K1 = 1.19 microM)。通过压力微喷射或灌流施加的5-HTP-DP(10 microM)拮抗了微喷射5-HT引起的肌间神经丛神经元的慢突触后去极化。5-HTP-DP还阻断了5-HT诱导的烟碱样快速突触电位幅度的突触前降低;然而,5-HTP-DP本身并不影响这些反应。此外,5-HTP-DP也未能影响肌间神经丛神经元对微喷射P物质的反应、它们对乙酰胆碱的毒蕈碱反应或逆向动作电位。相反,这两种二肽都阻断了在神经节间结缔组织中刺激纤维束后在II/AH型神经元中看到的慢突触电位。这些数据支持以下假设:肠道3H-5-HT结合位点是肠道神经5-HT受体,5-羟色氨酸的二肽是这些受体的特异性拮抗剂,并且5-HT是肌间神经丛中慢突触电位的介质之一。